The company has signed a letter of intent with PharmaCentra LLC subsidiary, CannabisBPO to support a clinical trial ecosystem built on standardized protocols and testing of cannabis products for use in the medical industry
TruTrace Technologies Inc () () said it has signed a letter of intent with Georgia-based PharmaCentra LLC to support a clinical trial ecosystem built on standardized protocols and testing of cannabis products for use in the medical industry.
PharmaCentra is a specialty contact provider with specific industry domain expertise in the pharmaceutical, healthcare and cannabis sectors. The group specializes in pharmaceutical marketing and sales strategies, strategic patient, pharmacy, and physician outreach.
The agreement with Vancouver-based TruTrace was signed through PharmaCentra’s subsidiary CannabisBPO, a specialty provider of contact centre services for the cannabis industry specializing in sales, customer care, lead generation, patient and customer journey and win back initiatives.
READ: TruTrace Technologies and Applied DNA Sciences join forces to deliver complete cannabis product validation and authentication platform
“As cannabis gains acceptance as a useful component of therapies to treat serious medical conditions, it is critical to ensure that all products used for patient care are safe and consistent,” TruTrace CEO Robert Galarza said in a statement Monday.
“This partnership is an important step toward making that a reality because there will be repeatable, verifiable processes for measuring the efficacy of cannabis-derived compounds that the entire biopharma industry can use to improve the quality of the therapies that are available to people who need them.”
PharmaCentra and CannabisBPO CEO Dan Berman said that the two firms are excited to play a key role in bringing pharmaceutical standards to the cannabis industry.
“We recognized that our background and service suite were transferable and necessary skills for the maturing cannabis market,” Berman told investors.
“We have deep knowledge in both sectors to bridge the knowledge gap between the two industries. In the pharmaceutical industry, the efficacy of the supply chain is rarely questioned – it’s just assumed to be measured correctly. Unfortunately, the same is not true for the cannabis sector as a whole. That’s why, together with TruTrace, we are excited to be playing a key role in bringing these standards to the industry,” he added.
TruTrace Technologies has developed fully integrated software, secured on a blockchain infrastructure, that gives clients the ability to store, manage, share and immediately access quality assurance and testing details, COAs, as well as motion and movement intelligence on inventory.
Contact Angela at angela@proactiveinvestors.com
Follow her on Twitter @AHarmantas